alexa Pharmacokinetic Changes Secondary to Roux en Y Gastric Bypass

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Global Summit on Pharmacology and Therapeutics

Vienna, Austria

European Summit on Pharmacology and Toxicology

Vienna, Austria

Advancement in Drug Discovery

New York, USA
Pharmacokinetic Changes Secondary to Roux en Y Gastric Bypass

Obesity is a growing epidemic leading to world-wide public health concerns. In 1999–2000, 27.5% of men and 33.4% of women were obese. The prevalence increased to 35.5% in men and 35.8% in women by 2009–2010. Bariatric surgery is an excellent option for patients with clinically severe obesity, defined as body mass index (BMI) of greater than 40 or BMI of >35 with serious comorbid conditions.

 

 

Citation: Giuliano C, Wilhelm SM, Kale-Pradhan PB (2012) Pharmacokinetic Changes Secondary to Roux en Y Gastric Bypass. Adv Pharmacoepidem Drug Safety S1:001. doi: 10.4172/2167-1052.S1-001

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Top